Provectus Biopharmaceuticals, Inc.
PVCT
$0.07
$0.017.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.25% | -60.00% | 1,203.72% | 2,068.89% | 301.31% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.21% | -23.05% | -29.88% | -28.62% | -26.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -82.63% | -78.72% | -93.76% | -88.80% | -55.77% |
| Total Current Assets | -41.86% | -63.42% | -28.98% | -35.62% | -28.43% |
|
|
|||||
| Total Current Assets | -41.86% | -63.42% | -28.98% | -35.62% | -28.43% |
| Net Property, Plant & Equipment | 339.32% | 237.86% | 174.20% | -76.07% | -64.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -30.69% | -47.64% | -15.65% | -38.25% | -30.54% |
|
|
|||||
| Total Accounts Payable | -35.28% | -14.71% | -0.82% | -45.69% | -33.97% |
| Total Accrued Expenses | 40.76% | 75.29% | -21.70% | -27.44% | -30.67% |
| Short-term Debt | 5.47% | -4.16% | -50.59% | -34.73% | -25.67% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.75% | -17.41% | -19.80% | -18.02% | 9.37% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -91.96% | -64.74% |
| Total Other Current Liabilities | -- | -- | -- | -91.96% | -64.74% |
| Total Current Liabilities | -1.12% | 3.97% | -22.42% | -32.65% | -22.64% |
|
|
|||||
| Total Current Liabilities | -1.12% | 3.97% | -22.42% | -32.65% | -22.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 5.47% | -4.16% | -50.59% | -34.73% | -25.67% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 0.35% | 5.82% | -21.18% | -32.75% | -22.86% |
|
|
|||||
| Common Stock & APIC | 2.02% | 2.36% | 3.23% | 3.14% | 2.60% |
| Retained Earnings | -2.11% | -2.60% | -2.49% | -2.12% | -1.87% |
| Treasury Stock & Other | 0.82% | -0.17% | 0.17% | -0.17% | -0.83% |
| Total Common Equity | -5.70% | -13.41% | 21.80% | 31.52% | 21.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 7.09% | 6.43% | 13.08% | -37.39% | -37.89% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 7.09% | 6.43% | 13.08% | -37.39% | -37.89% |
|
|
|||||
| Total Common Equity | -5.70% | -13.41% | 21.80% | 31.52% | 21.57% |
| Total Preferred Equity | 7.09% | 6.43% | 13.08% | -37.39% | -37.89% |
| Total Minority Interest | 59.60% | -- | -- | -- | -- |
| Total Equity | -5.59% | -13.73% | 21.81% | 31.96% | 21.39% |
|
|
|||||